Abstract
Platinum (Pt)–DNA adducts formed by the anti-tumor agent cisplatin are recognized by the DNA mismatch repair (MMR) system. To investigate the involvement of MMR proteins including hMLH1 in the removal of these adducts, we developed a mL-scale wet-digestion method for inductively coupled plasma mass spectrometry (ICP-MS). The detection limit was 0.01 ng mL−1 Pt, which corresponded to 2 pg Pt/μg DNA when 10 μg of DNA was used. The mean relative errors were 5.4% or better for a dynamic range of 0.01–10 ng mL−1 Pt. DNA (~500 μg) had no matrix effect. To improve the accuracy, DNA preparations were treated with ribonuclease and the apparent reduction in the concentration of Pt was corrected using cellular DNA levels, which were determined with Hoechst 33258. No significant differences were observed, in terms of the formation of Pt–DNA adducts or their removal over 6 h, between hMLH1-deficient HCT116 cells, a human colorectal cancer cell line, and hMLH1-complemented HCT116+ch3 cells (n=5; P>0.05), indicating that the hMLH1-dependent DNA repair systems contribute to neither the formation nor the removal of the adducts at detectable levels. In addition, approximately 19% of the adducts were removed within 6 h in both cell lines. A time course analysis (~24 h) suggested that the removal of cisplatin-generated Pt–DNA adducts follows first-order kinetics (t1/2=32 h). The amount of Pt–DNA adduct formed by oxaliplatin in 1 h was 56% (ratio of means) of that generated by an equimolar concentration of cisplatin in HCT116. The proposed procedure could be useful for determining Pt–DNA adducts formed by Pt(II) complexes.
Similar content being viewed by others
References
Jakupec MA, Galanski M, Keppler BK (2003) Rev Physiol Biochem Pharmacol 146:1–53
Kartalou M, Essigmann JM (2001) Mutat Res 478:23–43
Woynarowski JM, Faivre S, Herzig MCS, Arnett B, Chapman WG, Trevino AV, Raymond E, Chaney SG, Vaisman A, Varchenko M, Juniewicz PE (2000) Mol Pharmacol 58:920–927
May A, Nairn RS, Okumoto DS, Wassermann K, Stevnsner T, Jones JC, Bohr VA (1993) J Biol Chem 268:1650–1657
Moggs JG, Szymkowski DE, Yamada M, Karran P, Wood RD (1997) Nucleic Acids Res 25:480–490
de Laat WL, Jaspers NGJ, Hoeijmakers JHJ (1999) Genes Dev 13:768–785
Mellon I, Rajpal DK, Koi M, Boland CR, Champe GN (1996) Science 272:557–560
Duckett DR, Drummond JT, Murchie AIH, Reardon JT, Sancar A, Lilley DMJ, Modrich P (1996) Proc Natl Acad Sci USA 93:6443–6447
Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehmé A, Christen RD, Howell SB (1996) Cancer Res 56:4881–4886
Cenni B, Kim HK, Bubley GJ, Aebi S, Fink D, Teicher BA, Howell SB, Christen RD (1999) Br J Cancer 80:699–704
Lin X, Ramamurthi K, Mishima M, Kondo A, Christen RD, Howell SB (2001) Cancer Res 61:1508–1516
Arnould S, Hennebelle I, Canal P, Bugat R, Guichard S (2003) Eur J Cancer 39:112–119
Ding H, Goldberg MM, Raymer JH, Holmes J, Stanko J, Chaney SG (1999) Biol Trace Element Res 67:1–11
Morrison JG, White P, McDougall S, Firth JW, Woolfrey SG, Graham MA, Greenslade D (2000) J Pharm Biomed Anal 24:1–10
Zimmermann S, Menzel CM, Berner Z, Eckhardt JD, Stüben D, Alt F, Messerschmidt J, Taraschewski H, Sures B (2001) Anal Chim Acta 439:203–209
Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R (1996) Clin Cancer Res 2:1829–1835
Weber G, Messerschmidt J, Pieck AC, Junker AM, Wehmeier A, Jaehde U (2004) Anal Bioanal Chem 380:54–58
Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA, Boland CR (1994) Cancer Res 54:4308–4312 [published erratum appears in Cancer Res 1995 55:201]
Strauss WM (1998) In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds) Current protocols in molecular biology. Wiley, New York, pp 2.2.1–2.2.3
Labarca C, Paigen K (1980) Anal Biochem 102:344–352
Ghezzi A, Aceto M, Cassino C, Gabano E, Osella D (2004) J Inorg Biochem 98:73–78
Holmquist GP, Gao S (1997) Mutat Res 386:69–101
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamada, K., Kato, N., Takagi, A. et al. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes. Anal Bioanal Chem 382, 1702–1707 (2005). https://doi.org/10.1007/s00216-005-3339-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-005-3339-5